Stereotactic co-registration of magnetic resonance imaging and histopathology in post-mortem multiple sclerosis brain

Neuropathology and Applied Neurobiology

Volumn 29, Issue 6, 2003, Pages 596-601

  Schmierer, K ^a   Scaravilli, F ^b   Barker, G J ^a   Gordon, R ^a   MacManus, D G ^a   Miller, D H ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Co registration; Magnetic resonance imaging; Multiple sclerosis; Post mortem

Indexed keywords

FORMALDEHYDE;

ADULT; AGED; ARTICLE; AUTOPSY; CADAVER; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; EMBEDDING; FAST FLUID ATTENUATED INVERSION RECOVERY IMAGING; FEMALE; HEMATOXYLIN EOSIN STAINING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STAINING; STEREOTACTIC NAVIGATION; STEREOTAXIC SURGERY; TISSUE FIXATION; TISSUE SLICE;

BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POSTMORTEM CHANGES; SENSITIVITY AND SPECIFICITY; STEREOTAXIC TECHNIQUES; TISSUE FIXATION;

EID: 0346749653     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0305-1846.2003.00497.x     Document Type: Article

References (18)

1. Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti C, Bruck W. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol 2001; 49: 793-6
2. Blamire AM, Rowe JG, Styles P, McDonald B. Optimising imaging parameters for post mortem MR imaging of the human brain. Acta Radiol 1999; 40: 593-7
3. Boyko OB, Alston SR, Fuller GN, Hulette CM, Johnson GA, Burger PC. Utility of postmortem magnetic resonance imaging in clinical neuropathology. Arch Pathol Lab Med 1994; 118: 219-25
4. Brück W, Bitsch A, Kolenda H, Brück Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997; 42: 783-93
5. De Groot CJ, Bergers E, Kamphorst W, Ravid R, Polman CH, Barkhof F, van der Valk P. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 2001; 124: 1635-45
6. Gentleman SM, McKenzie JE, Royston MC, McIntosh TK, Graham DI. A comparison of manual and semi-automated methods in the assessment of axonal injury. Neuropathol Appl Neurobiol 1999; 25: 41-7
7. McFarland HF, Barkhof F, Antel J, Miller DH. The role of MRI as a surrogate outcome measure in multiple sclerosis. Mult Scler 2002; 8: 40-51
8. Maciunas RJ, Galloway RL Jr, Latimer JW. The application accuracy of stereotactic frames. Neurosurgery 1994; 35: 682-94
9. Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998; 121: 3-24
10. Moore GR, Leung E, MacKay AL, Vavasour IM, Whittall KP, Cover KS, Li DK, Hashimoto SA, Oger J, Sprinkle TJ, Paty DW. A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain. Neurology 2000; 55: 1506-10
11. Nabors LB, Songu-Mize E, Mize RR. Quantitative immunocytochemistry using an image analyzer. II. Concentration standards for transmitter immunocytochemistry. J Neurosci Meth 1988; 26: 25-34
12. Nagara H, Inoue T, Koga T, Kitaguchi T, Tateishi J, Goto I. Formalin fixed brains are useful for magnetic resonance imaging (MRI) study. J Neurol Sci 1987; 81: 67-77
13. Newcombe J, Hawkins CP, Henderson CL, Patel HA, Woodroofe MN, Hayes GM, Cuzner ML, MacManus D, du Boulay EP, McDonald WI. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain 1991; 114: 1013-23
14. Plummer DL. Dispimage: a display and analysis tool for medical images. Rev Neuroradiol 1992; 5: 489-95
15. Schmierer K, Scaravilli F, Griffin CM, Barker GJ, Miller DH. Quantitative assessment of lesion pathology in postmortem MS brain: a correlative MRI/histology study. Mult Scler 2002; 8 (Suppl. 1): S47
16. Truyen L, van Waesberghe JH, van Walderveen MA, van Oosten BW, Polman CH, Hommes OR, Ader HJ, Barkhof F. Accumulation of hypointense lesions ('black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996; 47: 1469-76
17. van Waesberghe JH, Kamphorst W, De Groot CJ, van Walderveen MA, Castelijns JA, Ravid R, Lycklama a Nijeholt GJ, van der Valk P, Polman CH, Thompson AJ, Barkhof F. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999; 46: 747-54
18. van Walderveen MA, Kamphorst W, Scheltens P, van Waesberghe JH, Ravid R, Valk J, Polman CH, Barkhof F. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998; 50: 1282-8